المؤلفون: Xu-Monette, Zijun Y, Dabaja, Bouthaina S, Wang, Xiaoxiao, Tu, Meifeng, Manyam, Ganiraju C, Tzankov, Alexander, Xia, Yi, Zhang, Li Li, Sun, Ruifang, Visco, Carlo, Dybkaer, Karen, Yin, Lihui, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L, Hsi, Eric D, Choi, William W L, van Krieken, J Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J M, Møller, Michael B, Parsons, Ben M, Zhao, Xiaoying, Winter, Jane N, Piris, Miguel A, McDonnell, Timothy J, Miranda, Roberto N, Li, Yong, Medeiros, L Jeffrey, Young, Ken H

المصدر: Xu-Monette , Z Y , Dabaja , B S , Wang , X , Tu , M , Manyam , G C , Tzankov , A , Xia , Y , Zhang , L L , Sun , R , Visco , C , Dybkaer , K , Yin , L , Chiu , A , Orazi , A , Zu , Y , Bhagat , G , Richards , K L , Hsi , E D , Choi , W W L , van Krieken , J H , Huh , J , Ponzoni , M , Ferreri ....

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Female, Gene Rearrangement, Genes, myc, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Kaplan-Meier Estimate, Lymphoma, Large B-Cell, Diffuse, Male, Middle Aged, Prednisone, Prognosis, Proportional Hazards Models, Proto-Oncogene Proteins c-myc, Rituximab, Transcriptome, Vincristine, Journal Article, Research Support, N.I.H., Extramural

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/680fbf05-14b7-42a6-8381-3dbd94d564b7Test

الإتاحة: https://doi.org/10.1038/modpathol.2015.118Test
https://portal.findresearcher.sdu.dk/da/publications/680fbf05-14b7-42a6-8381-3dbd94d564b7Test
https://findresearcher.sdu.dk/ws/files/135785627/modpathol2015118.pdfTest

المؤلفون: Xu-Monette Z. Y., Xiao M., Au Q., Padmanabhan R., Xu B., Hoe N., Rodriguez-Perales S., Torres-Ruiz R., Manyam G. C., Visco C., Miao Y., Tan X., Zhang H., Tzankov A., Wang J., Dybkaer K., Tam W., You H., Bhagat G., Hsi E. D., Ponzoni M., Ferreri A. J. M., Moller M. B., Piris M. A., Han van Krieken J., Winter J. N., Westin J. R., Pham L. V., Jeffrey Medeiros L., Rassidakis G. Z., Li Y., Freeman G. J., Young K. H.

المساهمون: Xu-Monette, Z. Y., Xiao, M., Au, Q., Padmanabhan, R., Xu, B., Hoe, N., Rodriguez-Perales, S., Torres-Ruiz, R., Manyam, G. C., Visco, C., Miao, Y., Tan, X., Zhang, H., Tzankov, A., Wang, J., Dybkaer, K., Tam, W., You, H., Bhagat, G., Hsi, E. D., Ponzoni, M., Ferreri, A. J. M., Moller, M. B., Piris, M. A., Han van Krieken, J., Winter, J. N., Westin, J. R., Pham, L. V., Jeffrey Medeiros, L., Rassidakis, G. Z., Li, Y., Freeman, G. J., Young, K. H.

مصطلحات موضوعية: Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, B7-H1 Antigen, CTLA-4 Antigen, Cyclophosphamide, Doxorubicin, Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic, Humans, Killer Cells, Natural, Lymphoma, Large B-Cell, Diffuse, Middle Aged, Phenotype, Prednisone, Prognosis, Programmed Cell Death 1 Receptor, Rituximab, T-Lymphocytes, Tumor Microenvironment, Vincristine

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000462983600012; volume:7; issue:4; firstpage:644; lastpage:657; numberofpages:14; journal:CANCER IMMUNOLOGY RESEARCH; http://hdl.handle.net/20.500.11768/109975Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85064144546

الإتاحة: https://doi.org/20.500.11768/109975Test
https://doi.org/10.1158/2326-6066.CIR-18-0439Test
https://hdl.handle.net/20.500.11768/109975Test

المؤلفون: M. Ponzoni, Wayne Tam, J.H.J.M. van Krieken, Lijuan Deng, Praveen Jain, Luis Fayad, Jianxiang Wang, Govind Bhagat, Ganiraju C. Manyam, Hagop M. Kantarjian, L. J. Medeiros, Y Liu, Ken H. Young, Karen Dybkær, Jorge E. Cortes, C. Visco, Yong Li, Jane N. Winter, Zhilei Yao, Robert Z. Orlowski, Anna Ferreri, Alexandar Tzankov, Zijun Y. Xu-Monette, M A Piris, Eric D. Hsi, Yongping Song, Michael Boe Møller

المساهمون: Yao, Z., Deng, L., Xu-Monette, Z. Y., Manyam, G. C., Jain, P., Tzankov, A., Visco, C., Bhagat, G., Wang, J., Dybkaer, K., Tam, W., Hsi, E. D., Van Krieken, J. H., Ponzoni, M., Ferreri, A. J. M., Moller, M. B., Winter, J. N., Piris, M. A., Fayad, L., Liu, Y., Song, Y., Orlowski, R. Z., Kantarjian, H., Medeiros, L. J., Li, Y., Cortes, J., Young, K. H.

المصدر: Leukemia, 32, 353-363
Yao, Z, Deng, L, Xu-Monette, Z Y, Manyam, G C, Jain, P, Tzankov, A, Visco, C, Bhagat, G, Wang, J, Dybkaer, K, Tam, W, Hsi, E D, van Krieken, J H, Ponzoni, M, Ferreri, A J M, Møller, M B, Winter, J N, Piris, M A, Fayad, L, Liu, Y, Song, Y, Orlowski, R Z, Kantarjian, H, Medeiros, L J, Li, Y, Cortes, J & Young, K H 2018, ' Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy ', Leukemia, vol. 32, no. 2, pp. 353-363 . https://doi.org/10.1038/leu.2017.222Test
Leukemia, 32, 2, pp. 353-363
Yao, Z, Deng, L, Xu-Monette, Z Y, Manyam, G C, Jain, P, Tzankov, A, Visco, C, Bhagat, G, Wang, J, Dybkær, K, Tam, W, Hsi, E D, van Krieken, J H, Ponzoni, M, Ferreri, A J M, Møller, M B, Winter, J N, Piris, M A, Fayad, L, Liu, Y, Song, Y, Orlowski, R Z, Kantarjian, H, Medeiros, L J, Li, Y, Cortes, J & Young, K H 2018, ' Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy ', Leukemia, vol. 32, no. 2, pp. 353–363 . https://doi.org/10.1038/leu.2017.222Test

مصطلحات موضوعية: Male, Oncology, Cancer Research, Pathology, Lymphoma, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], medicine.medical_treatment, 0302 clinical medicine, International Prognostic Index, Bone Marrow, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Stage (cooking), Aged, 80 and over, Bone Marrow/drug effects, Hematology, Middle Aged, Prognosis, Diffuse, Lymphoma, Large B-Cell, Diffuse/drug therapy, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Immunotherapy/methods, Female, Rituximab, Immunotherapy, Lymphoma, Large B-Cell, Diffuse, Adolescent, Adult, Aged, Disease-Free Survival, Humans, Immunologic Factors, Young Adult, medicine.drug, medicine.medical_specialty, Article, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Internal medicine, Large B-Cell, medicine, Performance status, business.industry, medicine.disease, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Bone marrow, business, Immunologic Factors/metabolism, Diffuse large B-cell lymphoma, 030215 immunology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65342ce8dea3970ce91b22ddf0256573Test
https://doi.org/10.1038/leu.2017.222Test

المؤلفون: Thai Tran, Min Xiao, Alexandar Tzankov, Mingzhi Zhang, J. Han van Krieken, Hua You, Ken H. Young, Nathan Roscoe, Jane N. Winter, Miguel A. Piris, Hongwei Zhang, Wayne Tam, Maurilio Ponzoni, L. Jeffrey Medeiros, Xiaohong Tan, Naveen Dakappagari, Ruifang Sun, Yong Li, Karen Dybkær, Govind Bhagat, Eric D Hsi, Jooryung Huh, Lisa Adams, Yi Miao, Carlo Visco, Zijun Y. Xu-Monette, Ling Li, Ganiraju C. Manyam, Bing Xu, Andrés J M Ferreri, Michael Boe Møller, Christine Vaupel, George Z. Rassidakis

المساهمون: Li, L., Sun, R., Miao, Y., Tran, T., Adams, L., Roscoe, N., Xu, B., Manyam, G. C., Tan, X., Zhang, H., Xiao, M., Tzankov, A., Visco, C., Dybkaer, K., Bhagat, G., Tam, W., Hsi, E. D., van Krieken, J. H., You, H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Moller, M. B., Piris, M. A., Zhang, M., Winter, J. N., Medeiros, L. J., Rassidakis, G. Z., Vaupel, C. A., Li, Y., Dakappagari, N., Xu-Monette, Z. Y., Young, K. H.

المصدر: Li, L, Sun, R, Miao, Y, Tran, T, Adams, L, Roscoe, N, Xu, B, Manyam, G C, Tan, X, Zhang, H, Xiao, M, Tzankov, A, Visco, C, Dybkaer, K, Bhagat, G, Tam, W, Hsi, E D, van Krieken, J H, You, H, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Piris, M A, Zhang, M, Winter, J N, Medeiros, L J, Rassidakis, G Z, Vaupel, C A, Li, Y, Dakappagari, N, Xu-Monette, Z Y & Young, K H 2019, ' PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration : a study from the International DLBCL Consortium Program ', Modern Pathology, vol. 32, no. 6, pp. 741-754 . https://doi.org/10.1038/s41379-018-0193-5Test
Modern Pathology, 32, 741-754
Modern Pathology, 32, 6, pp. 741-754

مصطلحات موضوعية: Male, 0301 basic medicine, Cell type, Pathology, medicine.medical_specialty, Programmed cell death, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], T-Lymphocytes, CD3, Programmed Cell Death 1 Receptor, Fluorescent Antibody Technique, B7-H1 Antigen, Pathology and Forensic Medicine, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Biomarkers, Tumor, Tumor Microenvironment, medicine, Humans, Aged, biology, business.industry, Middle Aged, Prognosis, medicine.disease, Immune checkpoint, Lymphoma, PD1, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, Immunohistochemistry, Female, Rituximab, Lymphoma, Large B-Cell, Diffuse, business, Diffuse large B-cell lymphoma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ddad34d19daa8a5e62f9c32af506ce2Test
https://portal.findresearcher.sdu.dk/da/publications/44d07c43-0f80-46c8-9d2a-619ed60dedafTest

المؤلفون: Hongwei Zhang, Karen Dybkær, Miguel A. Piris, Alexandar Tzankov, Jason R. Westin, Ziju Y. Xu-Monette, Jing Wang, Carlo Visco, Jane N. Winter, Maurilio Ponzoni, L. Jeffrey Medeiros, Yi Miao, Ganiraju C. Manyam, Bing Xu, Yong Li, Min Xiao, Hua You, Nicholas Hoe, Gordon J. Freeman, Raúl Torres-Ruiz, Andrés J.M. Ferreri, Wayne Tam, Ken H. Young, Qingyan Au, Govind Bhagat, George Z. Rassidakis, Xiaohong Tan, Eric D. Hsi, Sandra Rodriguez-Perales, Raghav Padmanabhan, Lan V. Pham, Michael Boe Møller, J. Han van Krieken

المساهمون: Xu-Monette, Z. Y., Xiao, M., Au, Q., Padmanabhan, R., Xu, B., Hoe, N., Rodriguez-Perales, S., Torres-Ruiz, R., Manyam, G. C., Visco, C., Miao, Y., Tan, X., Zhang, H., Tzankov, A., Wang, J., Dybkaer, K., Tam, W., You, H., Bhagat, G., Hsi, E. D., Ponzoni, M., Ferreri, A. J. M., Moller, M. B., Piris, M. A., Han van Krieken, J., Winter, J. N., Westin, J. R., Pham, L. V., Jeffrey Medeiros, L., Rassidakis, G. Z., Li, Y., Freeman, G. J., Young, K. H.

المصدر: Xu-Monette, Z Y, Xiao, M, Au, Q, Padmanabhan, R, Xu, B, Hoe, N, Rodríguez-Perales, S, Torres-Ruiz, R, Manyam, G C, Visco, C, Miao, Y, Tan, X, Zhang, H, Tzankov, A, Wang, J, Dybkær, K, Tam, W, You, H, Bhagat, G, Hsi, E D, Ponzoni, M, Ferreri, A J M, Møller, M B, Piris, M A, van Krieken, J H, Winter, J N, Westin, J R, Pham, L V, Medeiros, L J, Rassidakis, G Z, Li, Y, Freeman, G J & Young, K H 2019, ' Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL ', Cancer Immunology Research, vol. 7, no. 4, pp. 644-657 . https://doi.org/10.1158/2326-6066.CIR-18-0439Test
Cancer Immunology Research, 7, 644-657
Cancer Immunology Research, 7, 4, pp. 644-657
Xu-Monette, Z, Xiao, M, Au, Q, Padmanabhan, R, Xu, B, Hoe, N, Rodriguez-Perales, S, Torres-Ruiz, R, Manyam, G, Visco, C, Miao, Y, Tan, X, Zhang, H, Tzankov, A, Wang, J, Dybkaer, K, Tam, W, You, H, Bhagat, G, Hsi, E D, Ponzoni, M, Ferreri, A J M, Møller, M B, Piris, M A, van Krieken, J H, Winter, J N, Westin, J R, Pham, L V, Medeiros, L J, Rassidakis, G Z, Li, Y, Freeman, G J & Young, K H 2019, ' Immune profiling and quantitative analysis decipher the clinical role of immune checkpoint expression in the tumor immune microenvironment of DLBCL ', Cancer Immunology Research, vol. 7, no. 4, pp. 644-657 . https://doi.org/10.1158/2326-6066.CIR-18-0439Test

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Vincristine, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], T-Lymphocytes, Programmed Cell Death 1 Receptor, Immunology, B7-H1 Antigen, CHI3L1, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Antineoplastic Agents, Immunological, 0302 clinical medicine, Immune system, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Tumor Microenvironment, medicine, Humans, Neoplasm, CTLA-4 Antigen, Cyclophosphamide, CD20, biology, business.industry, Middle Aged, Prognosis, medicine.disease, Immune checkpoint, Lymphoma, Gene Expression Regulation, Neoplastic, Killer Cells, Natural, PD1, Phenotype, 030104 developmental biology, Doxorubicin, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Prednisone, Lymphoma, Large B-Cell, Diffuse, Rituximab, business, CD8, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd2bda5c650a913672e02e5151bffdabTest
http://hdl.handle.net/11562/1011409Test

المؤلفون: Thomas Menter, Yara Banz, Luca Mazzucchelli, Birgitta Sander, Christer Sundström, Marja-Liisa Karjalainen-Lindsberg, Sergio Cogliatti, Magnus Hultdin, Hanne Hawle, Klaus Beiske, Alexandar Tzankov, Stefanie Hayoz, Eva Kimby, Rainer Grobholz, Stefan Dirnhofer, Emanuele Zucca, Gieri Cathomas

المصدر: British journal of haematologyReferences. 189(4)

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Follicular lymphoma, Immunomodulation, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Tumor Microenvironment, Humans, Lymphoma, Follicular, Lenalidomide, Aged, Aged, 80 and over, Tumor microenvironment, Hematology, business.industry, GATA3, Middle Aged, medicine.disease, Prognosis, Progression-Free Survival, 3. Good health, Lymphoma, 030220 oncology & carcinogenesis, Rituximab, Female, business, CD8, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5bd15d3a4cee078a13b9206896f5b3dTest
https://pubmed.ncbi.nlm.nih.gov/32012230Test

المؤلفون: Hu, Shimin, Xu-Monette, Zijun Y, Balasubramanyam, Aarthi, Manyam, Ganiraju C, Visco, Carlo, Tzankov, Alexander, Liu, Wei-min, Miranda, Roberto N, Zhang, Li, Montes-Moreno, Santiago, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L, Hsi, Eric D, Choi, William WL, Han van Krieken, J, Huang, Qin, Huh, Jooryung, Ai, Weiyun, Ponzoni, Maurilio, Ferreri, Andrés JM, Zhao, Xiaoying, Winter, Jane N, Zhang, Mingzhi, Li, Ling, Møller, Michael B, Piris, Miguel A, Li, Yong, Go, Ronald S, Wu, Lin, Medeiros, L Jeffrey, Young, Ken H

مصطلحات موضوعية: Humans, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone, Antigens, CD30, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Prognosis, Disease-Free Survival, Treatment Outcome, Multivariate Analysis, Survival Analysis, Follow-Up Studies, Gene Expression Regulation, Neoplastic, Middle Aged, Female, Male, Lymphoma, Large B-Cell, Diffuse, Antibodies, Monoclonal, Murine-Derived, Transcriptome, Rituximab

وصف الملف: application/pdf

العلاقة: Blood; blood-2012-10-461848; https://hdl.handle.net/10161/19328Test

الإتاحة: https://hdl.handle.net/10161/19328Test

المؤلفون: Xu-Monette, Zijun Y, Møller, Michael B, Tzankov, Alexander, Montes-Moreno, Santiago, Hu, Wenwei, Manyam, Ganiraju C, Kristensen, Louise, Fan, Lei, Visco, Carlo, Dybkaer, Karen, Chiu, April, Tam, Wayne, Zu, Youli, Bhagat, Govind, Richards, Kristy L, Hsi, Eric D, Choi, William WL, van Krieken, J Han, Huang, Qin, Huh, Jooryung, Ai, Weiyun, Ponzoni, Maurilio, Ferreri, Andrés JM, Wu, Lin, Zhao, Xiaoying, Bueso-Ramos, Carlos E, Wang, Sa A, Go, Ronald S, Li, Yong, Winter, Jane N, Piris, Miguel A, Medeiros, L Jeffrey, Young, Ken H

مصطلحات موضوعية: Humans, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone, Antineoplastic Combined Chemotherapy Protocols, Immunologic Factors, Treatment Outcome, Risk Factors, Follow-Up Studies, Gene Expression Profiling, Genotype, Phenotype, Adult, Aged, Middle Aged, Female, Male, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-mdm2, Lymphoma, Large B-Cell, Diffuse, Antibodies, Monoclonal, Murine-Derived, Rituximab

وصف الملف: application/pdf

العلاقة: Blood; blood-2012-12-473702; https://hdl.handle.net/10161/19330Test

الإتاحة: https://hdl.handle.net/10161/19330Test

المؤلفون: Visco, C, Li, Y, Xu-Monette, ZY, Miranda, RN, Green, TM, Tzankov, A, Wen, W, Liu, W-M, Kahl, BS, d'Amore, ESG, Montes-Moreno, S, Dybkær, K, Chiu, A, Tam, W, Orazi, A, Zu, Y, Bhagat, G, Winter, JN, Wang, H-Y, O'Neill, S, Dunphy, CH, Hsi, ED, Zhao, XF, Go, RS, Choi, WWL, Zhou, F, Czader, M, Tong, J, Zhao, X, van Krieken, JH, Huang, Q, Ai, W, Etzell, J, Ponzoni, M, Ferreri, AJM, Piris, MA, Møller, MB, Bueso-Ramos, CE, Medeiros, LJ, Wu, L, Young, KH

مصطلحات موضوعية: Humans, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone, Antineoplastic Combined Chemotherapy Protocols, Immunoenzyme Techniques, Prognosis, Oligonucleotide Array Sequence Analysis, Tissue Array Analysis, Survival Rate, Gene Expression Profiling, Immunophenotyping, Algorithms, Middle Aged, Female, Male, Lymphoma, Large B-Cell, Diffuse, Antibodies, Monoclonal, Murine-Derived, Biomarkers, Tumor, Rituximab

وصف الملف: application/pdf

العلاقة: Leukemia; leu201283; https://hdl.handle.net/10161/19324Test

الإتاحة: https://hdl.handle.net/10161/19324Test

المؤلفون: Alexandar Tzankov, Dirk Klingbiel, Stephan Dirnhofer, Darius Juskevicius, David Jucker, Christoph Mamot

المصدر: Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-10 (2017)
Journal of Hematology & Oncology

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lymphoma, DNA Mutational Analysis, Targeted high-throughput sequencing, Bioinformatics, Antibodies, Monoclonal, Murine-Derived, Prognostic markers, 0302 clinical medicine, International Prognostic Index, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, SOCS1, Aged, 80 and over, EP300, Hematology, lcsh:Diseases of the blood and blood-forming organs, Middle Aged, Prognosis, CREBBP, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, CREB-Binding Protein, Survival Rate, Vincristine, 030220 oncology & carcinogenesis, NGS, Rituximab, Female, Lymphoma, Large B-Cell, Diffuse, Rapid Communication, medicine.drug, Adult, medicine.medical_specialty, Adolescent, lcsh:RC254-282, Disease-Free Survival, 03 medical and health sciences, Young Adult, Suppressor of Cytokine Signaling 1 Protein, Internal medicine, medicine, Humans, Molecular Biology, Survival rate, Cyclophosphamide, Survival analysis, Aged, business.industry, lcsh:RC633-647.5, medicine.disease, 030104 developmental biology, Doxorubicin, DLBCL, Mutation, Prednisone, business, Diffuse large B-cell lymphoma, E1A-Associated p300 Protein

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cb3eec6aae54ffa833d960f01052314Test
http://link.springer.com/article/10.1186/s13045-017-0438-7Test